BACKGROUND: Kidneys from deceased donors with acute renal failure (ARF) are generally not accepted for transplantation because of the expected poor outcome. This prospective study examined the utilization of kidneys from donors with ARF for transplantation and the outcomes. METHODS: Fifty-five kidneys from donors with ARF were transplanted. The outcome was compared with concurrent and matched 55 recipients of standard criteria donor (SCD) kidneys and 55 expanded criteria donor (ECD) kidneys. ARF kidneys were accepted from donors aged <50 years, a negative history for kidney disease, and a negative pretransplant biopsy for chronic structural changes. The immunosuppression was similar in all three groups. The outcome measurements included three-year patient and graft survival, biopsy-proven acute rejection (BPAR), subclinical acute rejection (SCAR), and chronic allograft nephropathy (CAN), serum creatinine, and creatinine clearance. RESULTS: Three-year patient and graft survival was 90% and 90% in ARF group, 100% and 89% in SCD group and 83% and 66% in ECD group. BPAR and SCAR were comparable in the groups but CAN was significantly higher in ECD group. Mean serum creatinine levels were 1.9+/-1.1, 1.9+/-0.9, and 2.2+/-1.3 mg/dl and mean creatinine clearances were 66+/-15, 68+/-14, and 58+/-10 mls/minute in ARF, SCD, and ECD groups, respectively (SCD and ARF vs. ECD P = 0.04). CONCLUSIONS: Transplantation of kidneys from selected deceased donors with ARF provides comparable survival and function compared to kidneys from non-ARF donors and may be considered for transplantation to expand the donor pool to overcome the current acute shortage of kidneys.
BACKGROUND: Kidneys from deceased donors with acute renal failure (ARF) are generally not accepted for transplantation because of the expected poor outcome. This prospective study examined the utilization of kidneys from donors with ARF for transplantation and the outcomes. METHODS: Fifty-five kidneys from donors with ARF were transplanted. The outcome was compared with concurrent and matched 55 recipients of standard criteria donor (SCD) kidneys and 55 expanded criteria donor (ECD) kidneys. ARF kidneys were accepted from donors aged <50 years, a negative history for kidney disease, and a negative pretransplant biopsy for chronic structural changes. The immunosuppression was similar in all three groups. The outcome measurements included three-year patient and graft survival, biopsy-proven acute rejection (BPAR), subclinical acute rejection (SCAR), and chronic allograft nephropathy (CAN), serum creatinine, and creatinine clearance. RESULTS: Three-year patient and graft survival was 90% and 90% in ARF group, 100% and 89% in SCD group and 83% and 66% in ECD group. BPAR and SCAR were comparable in the groups but CAN was significantly higher in ECD group. Mean serum creatinine levels were 1.9+/-1.1, 1.9+/-0.9, and 2.2+/-1.3 mg/dl and mean creatinine clearances were 66+/-15, 68+/-14, and 58+/-10 mls/minute in ARF, SCD, and ECD groups, respectively (SCD and ARF vs. ECD P = 0.04). CONCLUSIONS: Transplantation of kidneys from selected deceased donors with ARF provides comparable survival and function compared to kidneys from non-ARF donors and may be considered for transplantation to expand the donor pool to overcome the current acute shortage of kidneys.
Authors: Isaac E Hall; Enver Akalin; Jonathan S Bromberg; Mona D Doshi; Tom Greene; Meera N Harhay; Yaqi Jia; Sherry G Mansour; Sumit Mohan; Thangamani Muthukumar; Peter P Reese; Bernd Schröppel; Pooja Singh; Heather R Thiessen-Philbrook; Francis L Weng; Chirag R Parikh Journal: Kidney Int Date: 2018-11-20 Impact factor: 10.612
Authors: I E Hall; B Schröppel; M D Doshi; J Ficek; F L Weng; R D Hasz; H Thiessen-Philbrook; P P Reese; C R Parikh Journal: Am J Transplant Date: 2015-03-11 Impact factor: 8.086
Authors: Isaac E Hall; Peter P Reese; Francis L Weng; Bernd Schröppel; Mona D Doshi; Rick D Hasz; William Reitsma; Michael J Goldstein; Kwangik Hong; Chirag R Parikh Journal: Clin J Am Soc Nephrol Date: 2014-02-20 Impact factor: 8.237
Authors: Urs Benck; Peter Schnuelle; Bernd Krüger; Kai Nowak; Thomas Riester; Heiko Mundt; Niklas Lutz; Matthias Jung; Rainer Birck; Bernhard K Krämer; Wilhelm H Schmitt Journal: Int Urol Nephrol Date: 2015-10-26 Impact factor: 2.370
Authors: Jeong Ho Kim; Young Soo Kim; Min Seok Choi; Young Ok Kim; Sun Ae Yoon; Ji-Il Kim; In Sung Moon; Bum Soon Choi; Cheol Whee Park; Chul Woo Yang; Yong-Soo Kim; Byung Ha Chung Journal: BMC Nephrol Date: 2017-01-27 Impact factor: 2.388
Authors: Kyung Jai Ko; Young Hwa Kim; Mi Hyeong Kim; Kang Woong Jun; Kyung Hye Kwon; Hyung Sook Kim; Sang Dong Kim; Sun Cheol Park; Ji Il Kim; Sang Seob Yun; In Sung Moon; Jeong Kye Hwang Journal: Ann Surg Treat Res Date: 2018-10-25 Impact factor: 1.859
Authors: Neel Koyawala; Peter P Reese; Isaac E Hall; Yaqi Jia; Heather R Thiessen-Philbrook; Sherry G Mansour; Mona D Doshi; Enver Akalin; Jonathan S Bromberg; Meera N Harhay; Sumit Mohan; Thangamani Muthukumar; Bernd Schröppel; Pooja Singh; Francis L Weng; Chirag R Parikh Journal: Transplantation Date: 2020-06 Impact factor: 5.385